Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals

这一组合将创造一个涵盖仿制药、生物仿制药和品牌药物的加拿大健康冠军

Searchlight Pharma to become a division of Apotex and serve as its platform for expansion and growth of branded pharmaceuticals across the Americas

探照灯制药（Searchlight Pharma）将成为Apotex的一个部门，并作为其在美洲扩展和发展品牌制药的平台

TORONTO and MONTRÉAL, April 2, 2024 /PRNewswire/ - Canada's largest pharmaceutical company, Apotex Inc. ('Apotex') and Searchlight Pharma Inc. ('Searchlight'), one of Canada's fastest growing companies, announced today that they have reached an agreement whereby Apotex will acquire Searchlight.

多伦多和蒙特利尔，2024年4月2日，加拿大最大的制药公司Apotex Inc.（简称“Apotex”）和加拿大发展最快的公司之一探照灯制药公司（简称“探照灯”）今天宣布，他们已达成协议，Apotex将收购探照灯。

Searchlight is a private, top-growth Canadian specialty and innovative branded pharmaceutical company with global reach that executes best-in-class search, acquisition, commercialization, and focused development of innovative and unique specialty branded healthcare products.

探照灯是一家私人的、增长最快的加拿大专业和创新品牌制药公司，拥有全球影响力，执行一流的搜索、收购、商业化和创新独特的专业品牌保健产品的重点开发。

For nearly five decades, Apotex has leveraged its strong Canadian footprint into adjacent verticals, and building on its recent transaction with Harrow, Inc. for the exclusive rights to certain branded ophthalmic products, with the addition of Searchlight, is positioned to become the partner of choice for pharmaceutical licensing and acquisition opportunities in the Americas.

近50年来，Apotex利用其强大的加拿大足迹进入邻近的垂直市场，并在最近与Harrow，Inc.的交易基础上，获得了某些品牌眼科产品的独家权利，并增加了探照灯，有望成为美洲制药许可和收购机会的首选合作伙伴。

The acquisition further accelerates Apotex's growth within the specialty branded pharmaceutical market, adding a diverse portfolio of over 60 products and a full-service branded pharmaceutical platform, as well as established business development networks in Canada and internationally..

此次收购进一步加速了Apotex在专业品牌制药市场的增长，增加了60多种产品的多样化组合和全方位服务的品牌制药平台，以及在加拿大和国际上建立的业务发展网络。

'Searchlight has an experienced and proven track record as one of Canada's fastest-growing companies with deep institutional knowledge across a range of domestic and international markets and a strong specialty and innovative branded product portfolio,' said Allan Oberman, President and Chief Executive Officer at Apotex.

Apotex总裁兼首席执行官艾伦·奥伯曼（AllanOberman）说，“探照灯作为加拿大发展最快的公司之一，拥有丰富的国内和国际市场机构知识，拥有强大的专业和创新品牌产品组合，拥有丰富的经验和经验证的业绩记录。”

'This acquisition is a strategic complement to Apotex's leading market position in generic and biosimilar pharmaceuticals, in alignment with our ongoing focus to expand into the high-value, innovative branded pharmaceuticals sector. We look forward to working with Searchlight's talented team as we plan the integration of our companies and a seamless transition for patients, customers and employees.'.

“此次收购是对Apotex在仿制药和生物仿制药领域领先市场地位的战略性补充，与我们持续关注的高价值创新品牌制药领域相一致。我们期待着与探照灯的人才团队合作，为患者、客户和员工规划公司整合和无缝过渡。”

Mark Nawacki, Searchlight's President and Chief Executive Officer continued, 'For the past decade, Searchlight has successfully pursued its branded pharmaceutical growth strategy by providing dependability and value to Canadian patients and healthcare professionals. Thinking forward to an ambitious future, we know that Apotex is the right partner for Searchlight given our shared purpose of providing access to innovative medicines that improve people's lives.

Searchlight总裁兼首席执行官马克·纳瓦基（MarkNawacki）继续说道，“在过去的十年中，Searchlight通过为加拿大患者和医疗保健专业人员提供可靠性和价值，成功地推行了其品牌制药增长战略。展望雄心勃勃的未来，我们知道Apotex是探照灯的正确合作伙伴，因为我们的共同目标是提供改善人们生活的创新药物。

We are confident and excited that joining forces to create a Canadian pharmaceutical champion and global health company will harness a combined passion, scale and talent that will accelerate our plans.'.

我们有信心并感到兴奋的是，联手创建一家加拿大制药冠军和全球健康公司，将激发我们的热情、规模和人才，从而加速我们的计划。”

Closing of the transaction is subject to the satisfaction of customary regulatory conditions and expected to occur in the second quarter of 2024. Following close of the transaction, Searchlight's headquarters will remain based in Montreal and Apotex's operations will expand within the province of Quebec..

交易的完成取决于习惯监管条件的满足程度，预计将在2024年第二季度完成。交易结束后，探照灯的总部仍将设在蒙特利尔，Apotex的业务将在魁北克省范围内扩展。

Deutsche Bank Securities Inc. is serving as financial advisor to Apotex and Goodmans LLP is serving as legal counsel. Bloom Burton Securities Inc. is serving as financial advisor to Searchlight, and Davies Ward Phillips & Vineberg is serving as legal counsel.

德意志银行证券公司（Deutsche Bank Securities Inc.）担任Apotex的财务顾问，古德曼律师事务所（Goodmans LLP）担任法律顾问。Bloom Burton Securities Inc.担任Searchlight的财务顾问，Davies Ward Phillips＆Vineberg担任法律顾问。

About Apotex

关于Apotex

Apotex Inc. is a Canadian-based global health company that produces high-quality, affordable and complex medicines for patients around the world, with a strategic focus on becoming a Canadian Health Champion and an Americas Partner of Choice. Apotex has an integrated portfolio of generic, biosimilar and innovative branded pharmaceutical products for global markets.

Apotex Inc.是一家总部位于加拿大的全球健康公司，为世界各地的患者生产高质量，价格合理且复杂的药物，其战略重点是成为加拿大健康卫士和美国首选合作伙伴。Apotex为全球市场提供了仿制药、生物仿制药和创新品牌药品的综合组合。

Apotex employs almost 7,000 people worldwide in manufacturing, R&D, and commercial operations. Apotex medicines are accessible to patients in more than 75 countries globally. Apotex is comprised of multiple divisions and affiliates, including Apotex Inc., focused on generic and specialty innovative medicines in Canada and internationally, Apotex Corp., an affiliate of Apotex Inc.

Apotex在全球拥有近7000名员工，从事制造、研发和商业运营。Apotex药物可供全球75多个国家的患者使用。Apotex由多个部门和附属公司组成，包括Apotex Inc.，专注于加拿大和国际上的仿制药和专业创新药物，Apotex Corp.，Apotex Inc.的附属公司。

which markets and sells products in the United States, and Apobiologix, a division of Apotex Inc. focused on biosimilar medicines. For more information, visit www.apotex.com..

该公司在美国市场和销售产品，以及Apotex Inc.旗下专注于生物仿制药的部门Apobiologix。有关更多信息，请访问www.apotex.com。

About Searchlight

关于探照灯

Searchlight Pharma Inc., headquartered in Montreal, is a leading Canadian-based specialty healthcare company that executes best-in-class search, acquisition, commercialization, and focused development of innovative and unique specialty healthcare products.  Searchlight's core promoted products focus on women's health, dermatology, allergy, pain management and hospital specialty markets, and its team is committed to improving people's lives by bringing the right products to market.

总部位于蒙特利尔的Searchlight Pharma Inc.是一家加拿大领先的专业医疗保健公司，在创新和独特的专业医疗保健产品的搜索、收购、商业化和集中开发方面表现最佳。探照灯的核心推广产品专注于女性健康、皮肤病学、过敏、疼痛管理和医院专科市场，其团队致力于通过将正确的产品推向市场来改善人们的生活。